Astrazeneca Pharma India Ltd.

ASTRAZEN

₹9138.0

1.35% (121.5)

Market Cap

₹22,848 Cr.

P/E

124.61

Key Ratios

Edit Ratio's

Market cap

22,848 Cr

124

Prom Holding

75.00 %

ROE (%)

15.02

ROCE (%)

27.39

Div Yield (%)

0.35

Sales

1,855 Cr

OPM (%)

16.01 %

Debt to Equity

Edit Ratio's

About

AstraZeneca Pharma India Limited (AZPIL) operates as a subsidiary of AstraZeneca Plc, UK, and … Read more

Low

6220

52W Range

High

10691

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New

Edit rows

Forensics

10 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Promoter Holding

Promoter has not sold any shares in the last 90 days
Depreciation Effect

Company is depreciating a lower percentage of assets. this is contributing to an increase in net profit
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
ROE

Net profit margin is responsible for roe increase over last 10 years
Working Capital

Working capital of the company seems to be under control
Debt

Company should not have issues servicing its debt
Sales Growth

Sales of the company has grown at a good pace
ROCE Strength

Roce of the company is consistently strong
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Share price

Share price has increased over last 10 years but more due to rerating
Margin Stability

Margins of the company are volatile

Market Share

1.42 %

(as of Jul 22)

Historic

Anti - Diabetes - Market Share

0 %

(as of Jul 22)

Historic

Anti-Infectives - Market Share

1.71 %

(as of Nov 21)

Historic

Antineo Plastic - Market Share

0.56 %

(as of May 19)

Historic

Blood Related - Market Share

1.73 %

(as of Jul 22)

Historic

Cardiovascular - Market Share

0.94 %

(as of Nov 21)

Historic

Endocrinology - Market Share

0 %

(as of Jul 22)

Historic

Gastro-Intestinal - Market Share

0.45 %

(as of Jul 22)

Historic

Pharmaceutical Sector - Market Share

0.11 %

(as of Nov 21)

Historic

Respiratory - Market Share

1.96 %

(as of May 19)

Historic

Stomatological - Market Share

0 %

(as of Jul 22)

Historic

Vitamin & Dietary Supplements - Market Share

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Therapeutic Area Break-Up

Dosage Form Break-Up

Brand Wise Break-Up - Oncology

Operational Metrics

Domestic Sales Growth - YoY (%)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Brands

Crestor

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

Suppliers

Piramal Enterprises Ltd.
Cigniti Technologies Ltd.
Gulshan Polyols Ltd.
Take Solutions Ltd.
Vivimed Labs Ltd.

FAQs on Astrazeneca Pharma India Ltd. Business

What does Astrazeneca Pharma I do?

AstraZeneca Pharma India, a subsidiary of AstraZeneca Plc, focuses on delivering innovative medicines in cardiovascular, renal, metabolic diseases, oncology, and respiratory therapies.

Who are the competitors of Astrazeneca Pharma I?

Astrazeneca Pharma I major competitors are Eris Lifesciences, Pfizer, Wockhardt, Alembic Pharma, JB Chem & Pharma, Jubilant Pharmova, Caplin Point Lab.
Market Cap of Astrazeneca Pharma I is ₹22,547 Crs.
While the median market cap of its peers are ₹22,652 Crs.

Is Astrazeneca Pharma I financially stable compared to its competitors?

Astrazeneca Pharma I seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Cash Flow Machines

Actual Cash profits are more important than accounting profits. List of companies spitting out cash profits

Run Query

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	Jun Aug	Mar Jun Sep Dec						Jun
Investor Presentation							Mar Jun	Mar Jun Dec	Mar Jun Sep Dec	Jun Sep Dec	Dec		Mar	Dec
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Astrazeneca Pharma India Ltd.

View the discussion on ValuePickr

Pharmaceutical Sector

How The Pharma Industry Works - PPFAS

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Ideas Dashboard

Results

Timeline

Watchlist

Portfolio

Alerts

Stock Screener

Market

Raw Material

Astrazeneca Pharma India Ltd.

Astrazeneca Pharma India Ltd.

Key Ratios

About

Timeline

Company Timeline

Custom financial statement

Forensics

10 Yes

2 Neutral

5 No

0 No Data

Accounting & Shareholding

Contingent Liabilities

Other Income

Pledge

Retail Holding

Promoter Holding

Depreciation Effect

Revenue Recognition

Price & Performance

Capex vs ROCE

ROE

Working Capital

Debt

Sales Growth

ROCE Strength

Balance Sheet Strength

Current vs Historic Valuation

Share price

Margin Stability

Market Share

Revenue mix

Product Wise Break-Up

UNLOCK PREMIUM

Location Wise Break-Up

UNLOCK PREMIUM

Therapeutic Area Break-Up

UNLOCK PREMIUM

Dosage Form Break-Up

UNLOCK PREMIUM

Brand Wise Break-Up - Oncology

UNLOCK PREMIUM

Operational Metrics

Peer Comparison

Brands

Corporate Actions

Suppliers

FAQs on Astrazeneca Pharma India Ltd. Business

What does Astrazeneca Pharma I do?

Who are the competitors of Astrazeneca Pharma I?

Is Astrazeneca Pharma I financially stable compared to its competitors?

Similar Companies

Company Filing

Discussions & Analysis

SIGN UP FOR FREE